anticancer peptides review can inhibit tumour cell proliferation

Dr. Daniel Fisher logo
Dr. Daniel Fisher

anticancer peptides review ACPScanner - anticorp-anti-peptides-citrullines have been considered to target and kill cancer cells Anticancer Peptides Review: A Comprehensive Overview of Their Potential in Cancer Therapy

anticancer-peptides The field of oncology is continually seeking innovative and effective therapeutic strategies to combat cancer. Among the most promising avenues of research is the development and application of anticancer peptides (ACPs). These short chains of amino acids, typically composed of 10-60 amino acids, possess a remarkable ability to selectively target and eliminate cancer cells while sparing healthy ones. This review delves into the current research status of anticancer peptides, exploring their diverse mechanisms of action, sources, therapeutic potential, and the ongoing advancements in their development.Chemical Strategies towards the Development of Effective ...

ACPs are a superior choice of therapeutics compared to traditional treatments like antibodies and small molecules due to several inherent advantages. Their high selectivity, excellent penetration capabilities into tumor tissues, and ease of modification make them highly adaptable for various therapeutic applications. Research has highlighted that ACPs have promising potential as novel cancer therapeutics owing to their target specificity and a more favorable side effect profile than conventional therapies. Furthermore, ACPs can inhibit tumor cell proliferation through various intricate pathways.

Mechanisms of Action and Targeting Cancer Cells

The efficacy of anticancer peptides stems from their diverse modes of action. Many ACPs function by directly interacting with the cell membranes of cancer cells.ACPScanner: Prediction of Anticancer Peptides by Integrated ... Cancer cells often exhibit unique characteristics, such as a high negative charge on their surface, which can be exploited by positively charged ACPs. This interaction can lead to membrane permeabilization, disruption of cellular integrity, and ultimately, cell deathIn silico directed evolution of Anabas testudineus AtMP1 .... Several studies indicate that many ACPs induce apoptosis in cancer cells via mitochondrial membrane disruption and subsequent uptake into the cytoplasm.作者:YF Varela-Quitián·2025·被引用次数:6—Thisreviewfocuses on CAMPs withanticancerproperties, such as KLA, bovine lactoferricin derivatives, and LTX-315, and briefly explores common bioinformatics ...

Beyond direct cytotoxicity, anticancer peptides can also exert their effects through immunomodulatory mechanisms.From antimicrobial to anticancer peptides. A review Some ACPs can stimulate the immune system to recognize and attack cancer cells, thereby enhancing the body's natural defense against the disease. This dual action – direct killing of tumor cells and boosting the immune response – positions anticancer peptides as powerful tools in the fight against cancer.Review Current research status of anti-cancer peptides It is also noted that ACPs have been considered to target and kill cancer cells due to these unique cellular characteristicsAnticancer peptide: Physicochemical property, functional ....

Sources and Diversity of Anticancer Peptides

Anticancer peptides are not confined to synthetic laboratories; they are found in a variety of natural sources. Research has explored animal sources from which bioactive peptides with anticancer activity are derived, revealing a rich reservoir of potential therapeutic agents. For instance, peptides derived from milk proteins, eggs, and even venom have demonstrated significant antitumor activities作者:S Fazry·2024—In silico directed evolution of Anabas testudineus AtMP1 antimicrobial peptide to improve in vitroanticanceractivity. Research Article.. Food-derived bioactive peptides are also gaining considerable attention as suitable alternatives for cancer management, offering a more accessible and potentially safer source of therapeutic compounds.

The diversity of ACPs is further expanded by modifications and the exploration of different peptide families. Antimicrobial peptides (AMPs), originally studied for their antibacterial properties, have been found to possess potent anticancer activity as well. This overlap in function has led to significant research into antimicrobial peptides with anticancer properties, with some AMPs proving to be effective tumoricidal agents against human cancer cells. This dual functionality underscores the versatility of peptides in therapeutic development.

Therapeutic Applications and Future Directions

The potential applications of anticancer peptides are vast and continue to expand. They are being investigated as standalone therapies, as well as in combination with existing treatments. ACPs improve drug delivery efficiency by co-administration with chemotherapy drugs or by modifying nanoparticles, potentially enhancing the efficacy of conventional treatments while reducing systemic toxicityReview Current research status of anti-cancer peptides. Research into anti-breast cancer peptides is particularly active, with several promising candidates emerging for this prevalent form of cancer.Anticancer peptides as novel immunomodulatory ... Indeed, anticancer peptides have emerged as a promising new category of treatment options for breast cancer.

The development of anticancer peptides is being significantly aided by advancements in computational tools and bioinformatics. Platforms like ACPScanner and databases such as PeptiHub are crucial for identifying, characterizing, and predicting the efficacy of novel ACPs. These tools facilitate the discovery of biologically active peptides with antitumor activities and help in understanding their complex interactions作者:S Zareei·2024·被引用次数:15—While somepeptidesdemonstrated significantanticancerefficacy, others exhibited no discernible impact, and some even possessed alternative .... The ability to accurately predict anticancer peptide activity using machine learning tools is revolutionizing the discovery pipeline.

While peptides exhibit lower affinity and a shorter half-life in the body than antibodies, they demonstrate higher efficiency in certain contexts and can be more readily produced. Efforts are underway to overcome these limitations through chemical modifications and formulation strategies, leading to an increase in the effectiveness of cancer therapyACPScanner: Prediction of Anticancer Peptides by Integrated .... The focus is on optimizing peptide sequences and delivery methods to enhance their therapeutic index.

In conclusion, the field of anticancer peptides represents a dynamic and exciting frontier in cancer research.Anticancer peptides as novel immunomodulatory ... With their inherent selectivity, diverse mechanisms of action, and potential for modification, anticancer peptides have great selectivity and penetration efficiency, offering a promising alternative and complementary approach to current cancer therapies. Continued research into their discovery, characterization, and clinical application holds the key to unlocking their full potential in improving patient outcomes作者:D Gaspar·2013·被引用次数:909—In thisreviewwe provide an overview of the literature concerningpeptides' structure, modes of action, selectivity, and efficacy. This ongoing review of anticancer peptides is vital for understanding their current capabilities and future trajectory in oncologyPeptide-Based Agents for Cancer Treatment - PubMed Central - NIH.

Log In

Sign Up
Reset Password
Subscribe to Newsletter

Join the newsletter to receive news, updates, new products and freebies in your inbox.